Cattle Healthcare Market: By Product Type (Vaccines, Pharmaceuticals and Feed Additives), By Animal Type (Beef Cattle, Dairy Cattle and Oxen) and By Geography     

Cattle Healthcare Market size was valued at 3.0 billion in 2022 and is estimated to reach 5.1 billion by 2029 growing at a CAGR of 7.9% during the forecast period 2023 to 2029. Some of the key factors fueling the market growth include increasing spendings on R&D in the cattle health sector, rapid growth in population coupled with urbanization, growing production of beef, spreading of diseases through cattle and rising initiatives by governments and insurance policies in different countries. However, lack of infrastructure and regulatory challenges are inhibiting the market growth. The toxoids or killed vaccinations are available for a variety of diseases and are known to produce adverse reactions. The chemically altered vaccinations produce similar results as the live vaccines that have been modified. The vaccine industry is expanding its reach thanks to rising cow populations, more R&D spending, and new technologies. Vaccinations for respiratory infections, clostridial vaccines, botulism vaccines, and vaccinations for diseases that cause infertility or abortion in cattle are all available on the market.